Pure Global AI
Registration holder profile

ABBOTT DIAGNOSTICOS RAPIDOS S.A.

Brazil147 ANVISA registrations58 unique technical categoriesNov 17, 2008 – Jul 27, 2026
Verified
147
Total products
58
Technical names
Nov 2008
Earliest registration
Jul 2026
Latest registration
Regulatory footprint
Search ABBOTT DIAGNOSTICOS RAPIDOS S.A. across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this holder
STAPHYLOCOCCUS SP
Clearview PBP2a SA
Class III · Jul 27, 2026
Lancets
Lancetas de segurança Tianjin Unistik Touch
Class II · Jun 22, 2026
Lancets
Lancetas de segurança Tianjin ABON
Class II · Jun 22, 2026
ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
HIV 1/2 Human Immunodeficiency Virus Rapid Test Device
Class IV · May 11, 2026
COMBINED PARAMETERS - RESPIRATORY PANEL
Panbio COVID-19 Flu A&B Panel Positive Controls (Nasal)
Class III · Apr 13, 2026
Most popular products
Products with most registrations
DRUGS OF ABUSE PANEL
14 registrations
Lancets
11 registrations
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
11 registrations
DENGUE
9 registrations
CORONAVIRUS
5 registrations
Top manufacturers
Manufacturers with the most products registered by this holder
ABBOTT DIAGNOSTICS KOREA INC.
29 products
ABBOTT RAPID DIAGNOSTICS JENA GMBH
20 products
ABON BIOPHARM (HANGZHOU) CO LTD
17 products
ABBOTT DIAGNOSTICS SCARBOROUGH, INC
15 products
ABBOTT DIAGNOSTICS TECHNOLOGIES AS
14 products
Products per risk level
Distribution of distinct commercial products by ANVISA risk classification
Class I9Distinct Products · 9 total registrations
Class II79Distinct Products · 79 total registrations
Class III34Distinct Products · 34 total registrations
Class IV25Distinct Products · 25 total registrations
About this profile

Access comprehensive registration holder profile for ABBOTT DIAGNOSTICOS RAPIDOS S.A. through Pure Global AI's free Brazil medical device database. This registration holder manages 147 medical device registrations with ANVISA across 58 unique technical categories. Their regulatory portfolio spans from Nov 17, 2008 to Jul 27, 2026.

This page provides comprehensive insights including 5 recent product registrations with the latest being STAPHYLOCOCCUS SP (Clearview PBP2a SA), 5 most popular products led by DRUGS OF ABUSE PANEL with 14 registrations, partnerships with 5 key manufacturers including ABBOTT DIAGNOSTICS KOREA INC. and ABBOTT RAPID DIAGNOSTICS JENA GMBH, and products across 4 risk classifications with 9 Class I devices. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping distributors understand market dynamics and identify business opportunities.